Stendra
developed to address erectile dysfunction to mitigate concerns relating to sexual performance.
Strengths: 50 · 100 · 200mg
Where to Check Availability
Medicine details
- Conditions
- Alternative names
Spedra
- Therapeutic class
Phosphodiesterase-5 Inhibitor
- Pharmacological class
PDE5 Inhibitor
- Minor side effects
headache; flushing; nasal congestion
- Moderate side effects
back pain; dyspepsia; dizziness
- Dosage forms
Tablet
- Administration route
Oral use
- Prescription status
POM
- Manufacturer
Menarini
- Onset Time
15–30 minutes
- Duration
4–6 hours
- Storage instructions
Store in a cool, dry place.
- Drug interactions
nitrates; alpha-blockers; cytochrome p450 inhibitors
- Age restrictions
Adults only.
- Pregnancy and breastfeeding
Not applicable.
Contraindications
concurrent use of nitrates; hypersensitivity to avanafil; recent myocardial infarction; severe hypotension
Precautions and warnings
seek care for erections lasting more than four hours; monitor blood pressure; use caution in patients with hepatic impairment
Serious side effects
priapism — requires immediate medical attention; sudden vision loss — requires immediate medical attention; severe cardiovascular event — requires immediate medical attention
Patient summary
developed to address erectile dysfunction to mitigate concerns relating to sexual performance.
Mechanism of action
Avanafil is a highly selective, reversible inhibitor of PDE5. By increasing cyclic guanosine monophosphate (cGMP) in the smooth muscle tissues, it promotes relaxation and improves blood flow to the erectile tissues during sexual arousal.
Stendra
developed to address erectile dysfunction to mitigate concerns relating to sexual performance.
Editorial Notes
- Active ingredient(s): Avanafil
- Listed indication(s): Erectile Dysfunction
Usually available as
- 24 tablets - 50 mg763-50-mg-5733
- 24 tablets - 100 mg763-100-mg-5727
- 20 tablets - 200 mg763-200-mg-12906